Search

Your search keyword '"Schiavoni G."' showing total 356 results

Search Constraints

Start Over You searched for: Author "Schiavoni G." Remove constraint Author: "Schiavoni G."
356 results on '"Schiavoni G."'

Search Results

201. BRAF mutations in hairy-cell leukemia.

202. Type I IFNs control antigen retention and survival of CD8α(+) dendritic cells after uptake of tumor apoptotic cells leading to cross-priming.

203. Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.

204. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.

205. Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry.

206. Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.

207. Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry.

209. Thrombus aspiration without additional ballooning or stenting to treat selected patients with ST-elevation myocardial infarction.

210. Regulation of immune cell homeostasis by type I interferons.

211. Chlamydia pneumoniae infection as a risk factor for accelerated atherosclerosis in hemodialysis patients.

212. Renal artery stenting in patients with chronic ischemic heart disease.

213. Activation of TM7SF2 promoter by SREBP-2 depends on a new sterol regulatory element, a GC-box, and an inverted CCAAT-box.

214. Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry.

215. Type I IFN regulate DC turnover in vivo.

216. Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha.

217. Evaluation of a strategy for treating bifurcated lesions by single or double stenting based on the Medina classification.

218. Chlamydia pneumoniae and atherosclerosis: the role of mast cells.

219. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.

220. Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry.

222. Disruption of the gene encoding 3beta-hydroxysterol Delta-reductase (Tm7sf2) in mice does not impair cholesterol biosynthesis.

223. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.

224. Impact of metabolic syndrome on angiographic and clinical outcome after stenting.

225. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.

226. Comparison of the transradial and transfemoral approaches for coronary angiographic evaluation in patients with internal mammary artery grafts.

227. Adjunctive devices in primary or rescue PCI: a meta-analysis of randomized trials.

228. Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease.

229. Real time PCR for detection of Chlamydophila pneumoniae in peripheral blood mononuclear cells of patients with multiple sclerosis.

230. Feasibility of sequential thrombus aspiration and filter distal protection in the management of very high thrombus burden lesions.

231. Outcome of overlapping heterogenous drug-eluting stents and of overlapping drug-eluting and bare metal stents.

232. Patients with in-stent restenosis have an increased risk of mid-term venous graft failure.

233. ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD4+ T cells.

234. STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.

235. A pilot study with a new, rapid-exchange, thrombus-aspirating device in patients with thrombus-containing lesions: the Diver C.E. study.

236. GL15 and U251 glioblastoma-derived human cell lines are peculiarly susceptible to induction of mitotic death by very low concentrations of okadaic acid.

237. Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial.

238. Use of a novel high-osmolar gadolinium chelate, gadobutrol, for percutaneous renal artery stenting in two patients with chronic renal failure.

239. Use of a second buddy wire during percutaneous coronary interventions: a simple solution for some challenging situations.

240. Percutaneous treatment of a large coronary aneurysm using the self-expandable Symbiot PTFE-covered stent.

241. Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway.

242. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells.

243. Selective intracoronary injection of sestamibi to detect myocardial viability: Prediction of perfusion and contractile recovery after percutaneous transluminal coronary angioplasty.

244. Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease.

245. Early vasoreactive profile of skeletonized versus pedicled internal thoracic artery grafts.

246. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8alpha(+) dendritic cells.

247. Prothrombotic response to coronary angioplasty in patients with unstable angina and raised C-reactive protein.

248. Combined percutaneous pulmonary valvuloplasty and patent foramen ovale closure in an adult with recurrent transient ischemic attacks.

249. Type I interferons produced by dendritic cells promote their phenotypic and functional activation.

250. Microbiological indoor air quality in healthy buildings.

Catalog

Books, media, physical & digital resources